title: In vitro cross-resistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations.
abstract: BMS-986001 is a novel HIV nucleoside reverse transcriptase inhibitor (NRTI). To date, little is known about its resistance profile. In order to examine the cross-resistance profile of BMS-986001 to NRTI mutations, a replicating virus system was used to examine specific amino acid mutations known to confer resistance to various NRTIs. In addition, reverse transcriptases from 19 clinical isolates with various NRTI mutations were examined in the Monogram PhenoSense HIV assay. In the site-directed mutagenesis studies, a virus containing a K65R substitution exhibited a 0.4-fold change in 50% effective concentration (EC50) versus the wild type, while the majority of viruses with the Q151M constellation (without M184V) exhibited changes in EC50 versus wild type of 0.23- to 0.48-fold. Susceptibility to BMS-986001 was also maintained in an L74V-containing virus (0.7-fold change), while an M184V-only-containing virus induced a 2- to 3-fold decrease in susceptibility. Increasing numbers of thymidine analog mutation pattern 1 (TAM-1) pathway mutations correlated with decreases in susceptibility to BMS-986001, while viruses with TAM-2 pathway mutations exhibited a 5- to 8-fold decrease in susceptibility, regardless of the number of TAMs. A 22-fold decrease in susceptibility to BMS-986001 was observed in a site-directed mutant containing the T69 insertion complex. Common non-NRTI (NNRTI) mutations had little impact on susceptibility to BMS-986001. The results from the site-directed mutants correlated well with the more complicated genotypes found in NRTI-resistant clinical isolates. Data from clinical studies are needed to determine the clinically relevant resistance cutoff values for BMS-986001.
authors: Bristol-Myers Squibb, Research and Development, Wallingford, Connecticut, USA.
authors: Zhufang
authors: Z
authors: Li
authors: Brian
authors: B
authors: Terry
authors: William
authors: W
authors: Olds
authors: Tricia
authors: T
authors: Protack
authors: Carol
authors: C
authors: Deminie
authors: Beatrice
authors: B
authors: Minassian
authors: Beata
authors: B
authors: Nowicka-Sans
authors: Yongnian
authors: Y
authors: Sun
authors: Ira
authors: I
authors: Dicker
authors: Carey
authors: C
authors: Hwang
authors: Max
authors: M
authors: Lataillade
authors: George J
authors: GJ
authors: Hanna
authors: Mark
authors: M
authors: Krystal
mesh_terms: D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D013936:Thymidine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: C583040:BMS-986001; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase; D013936:Thymidine
references: Antivir Ther. 1999;4(2):69-77
references: 10682151
references: J Clin Microbiol. 1999 Dec;37(12):4099-106
references: 10565938
references: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):346-54
references: 23771104
references: J Infect Dis. 1994 Apr;169(4):722-9
references: 8133086
references: Antimicrob Agents Chemother. 1994 Feb;38(2):275-81
references: 7514855
references: J Mol Biol. 2007 Jan 12;365(2):298-309
references: 17070543
references: Antimicrob Agents Chemother. 1993 Jun;37(6):1390-2
references: 8392313
references: Antimicrob Agents Chemother. 2005 Jul;49(7):2575-82
references: 15980322
references: EMBO J. 2000 Nov 1;19(21):5752-61
references: 11060026
references: J Infect Dis. 2000 Mar;181(3):904-11
references: 10720511
references: AIDS. 2000 Jan 28;14(2):163-71
references: 10708287
references: Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):1025-8
references: 11562951
references: Antimicrob Agents Chemother. 1993 Apr;37(4):875-81
references: 7684216
references: J Infect Dis. 2000 Mar;181(3):912-20
references: 10720512
references: Science. 1998 Nov 27;282(5394):1669-75
references: 9831551
references: J Med Virol. 2004 Jan;72(1):162-5
references: 14635026
references: AIDS Rev. 2004 Jan-Mar;6(1):22-33
references: 15168738
references: Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2398-402
references: 7534421
references: Antimicrob Agents Chemother. 2012 May;56(5):2305-13
references: 22330916
references: Antimicrob Agents Chemother. 2011 Feb;55(2):895-903
references: 21078952
references: Antimicrob Agents Chemother. 2004 Apr;48(4):1413-5
references: 15047556
references: Antimicrob Agents Chemother. 1993 Oct;37(10):2231-4
references: 7504909
references: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2760-4
references: 7535930
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3355-60
references: 16048947
references: Antivir Chem Chemother. 2007;18(6):307-16
references: 18320935
references: Clin Infect Dis. 2003 Oct 1;37(7):944-50
references: 13130407
references: Antimicrob Agents Chemother. 1999 Aug;43(8):1961-7
references: 10428920
references: Antimicrob Agents Chemother. 2009 Nov;53(11):4640-6
references: 19704131
references: Antiviral Res. 2007 Mar;73(3):185-91
references: 17109975
references: Curr Pharm Des. 2013;19(10):1880-97
references: 23092278
references: Antimicrob Agents Chemother. 2003 Nov;47(11):3377-83
references: 14576091
references: J Acquir Immune Defic Syndr. 2003 May 1;33(1):15-21
references: 12792350
references: Antivir Ther. 1999;4(2):87-94
references: 10682153
references: Antimicrob Agents Chemother. 2004 May;48(5):1640-6
references: 15105115
references: Antivir Ther. 2003 Dec;8(6):489-506
references: 14760883
references: Antimicrob Agents Chemother. 1997 May;41(5):1094-8
references: 9145875
references: Antimicrob Agents Chemother. 2006 Dec;50(12):4087-95
references: 16982781
references: J Infect Dis. 1999 Jan;179(1):92-100
references: 9841827
references: Nucleosides Nucleotides Nucleic Acids. 2006;25(1):89-107
references: 16440988
references: Antivir Chem Chemother. 2005;16(4):217-21
references: 16130520